Advanced glycation end product (AGE)-induced vascular smooth muscle cell (VSMC) proliferation is vital to the progression of diabetic vasculopathy. A grape seed procyanidin extract has been reported to possess anti-oxidative and anti-inflammatory properties and to display a significant cardiovascular protective effect, but little is know about the underlying mechanism. The objective of this present study was to determine whether GSPB2 (grape seed procyanidin B2), which is a dimeric procyanidin and more biologically active, could inhibit AGE-induced VSMC proliferation by affecting the production of ubiquitin COOH-terminal hydrolase 1 (UCH-L1), the degradation of IB-and nuclear translocation of NF-B in human aortic smooth muscle cells (HASMCs). Our data show that GSPB2 preincubation markedly inhibited AGE-induced proliferation and migration of HASMCs in a dose-dependent manner and upregulated the protein level of UCH-L1. Further studies revealed that the GSPB2 pretreatment markedly attenuated the degradation of IB-and nuclear translocation of NF-B by modulating ubiquitination of IB-in AGEexposed HASMCs. These results collectively suggest that AGE-induced HASMC proliferation and migration was suppressed by GSPB2 through regulating UCH-L1 and ubiquitination of IB-. GSPB2 may therefore have therapeutic potential in preventing and treating vascular complications of diabetes mellitus.
It is well known that hyperglycemia in diabetic patients can increase the risk of developing such cardiovascular complications as atherosclerosis and hypertension. 1, 2) It accelerates the progression of cardiovascular disease by effecting wall thickening in large arteries. 3) This effect is particularly marked by the proliferation of vascular smooth muscle cells (VSMCs).
However, the mechanism linking hyperglycemia and the pathogenesis of macrovascular disease remains to be further defined.
There is growing evidence that the production and accumulation of advanced glycation end products (AGEs) is involved in the pathogenesis of diabetic vascular complications. 4) Binding of AGEs to their receptor RAGE on VSMCs leads to an intracellular oxidative stress response through the increased activation of transcription factors such as NF-B. 5, 6) Many studies have shown that the NF-B signal pathway is associated with VSMC migration, invasion and proliferation. 7) IB proteins are known to regulate NF-B activity in the cytoplasm. IB-is forwarded to be ubiquitinated by the relevant enzyme and degraded by the 26S proteasome in response to extracellular stimuli. NF-B is subsequently translocated to the nucleus and activates gene transcription. 8) The ubiquitin-proteasome system is involved in the regulation of such cellular processes as the degradation of intracellular proteins, proliferation and signal transduction. Recent studies have shown that the increased ubiquitin-proteasome activity induced by oxidative stress may play a crucial role in the progression of atherosclerosis in diabetic patients. 9) In contrast, the de-ubiquitinating enzymes are negative regulators of ubiquitin-dependent proteolysis. UCHs (ubiquitin COOH-terminal hydrolases) 10) are known as a member of the family of de-ubiquitinating enzymes. As one of the UCH isozymes, UCH-L1 was first found to be predominantly expressed in central and peripheral neurons and to be involved in the pathogenesis of such neurodegenerative disorders as Parkinson's disease and Alzheimer's disease.
11) It has been reported that UCH-L1 was also expressed in endothelial cells and smooth muscle cells in atherosclerotic lesions from human carotid arteries. 12) Grape seed procyanidin extracts (GSPEs) derived from grape seeds have been shown to exert radicalscavenging, anti-oxidative, anti-inflammatory and antitumorial effects. [13] [14] [15] Dimeric procyanidin B2 is one of the components of GSPE which may be more active than other water-soluble polyphenols in its biological activities, i.e., inhibiting the formation of AGEs in the BSA-glucose model and nNOS activity in vitro. [16] [17] [18] The objective of the present study is to determine whether grape seed procyanidin B2 (GSPB2) has the capability to inhibit the AGE-induced proliferation and migration of human aortic smooth muscle cells (HASMCs) and to clarify the underlying molecular mechanism for the effect of GSPB2 on NF-B translocation by affecting the production of the de-ubiquitinating enzyme, UCH-L1.
Materials and Methods
Materials. GSPB2 (more than 95% pure, lot no. 20080915) was provided by Jianfeng (Tianjin, China). Bovine serum albumin (BSA), d-glucose, collagenase, a trypsin/EDTA solution, dimethyl sulfoxide (DMSO) and 3-(4,5-dimethylthiazol)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma (St. Louis, USA). Fetal bovine serum (FBS) was obtained from Gibco (Grand Island, USA), and HASMCs and the smooth muscle cell medium (SMCM) were obtained from ScienCell Research Laboratories (California, USA). The antibodies of total UCH-L1, IB-, and NF-B were purchased from Cell Signaling Technology (Beverly, USA). Tissue culture flasks and plates were supplied by Costar (Cambridge, USA), and all other reagents were of standard commercial high-purity grade.
AGE-BSA preparation. AGEs were prepared by incubating 50 mg/mL of BSA with 0.5 mol/L of glucose in 0.2 mol/L of phosphate-buffered saline (PBS, pH 7.4) in the dark at 37 C for 12 weeks. The solution was sterilized by passing it through a 0.2-mm filter before incubation. Unmodified BSA was incubated under the same conditions in the absence of glucose as a control. The unincorporated sugars were removed by extensive dialysis after incubation. The concentration of AGEs was determined by V-2001 fluorescence spectrophotometry (Hitachi, Japan; 390 nm excitation wavelength, 450 nm emission wavelength). The fluorescence values for the test substances were measured at a protein concentration of 1 mg/mL, the results being expressed as AGE units (1 U ¼ 1 mg/mL of the AGE-BSA standard). The AGE concentration in AGE-modified BSA was 94.5 U/mg of proteins, whereas that in the control group was 0.5 U/mg of proteins. The endotoxin concentration was measured by the limulus amebocyte lysate assay (Sigma, St. Louis, USA) which revealed negligible values (<0:2 mg/L).
Cell cultures. SMCM consisted of 500 mL of the basal medium, 10 mL of fetal bovine serum (FBS, cat. no. 0010), 5 mL of a smooth muscle cell growth supplement (0.5 ng/mL of EGF, 5 mg/mL of insulin, 2 ng/mL of bFGF, 50 ng/mL of Amphotericin B and 50 mg/mL of gentamicin), and 5 mL of a penicillin (100 U/mL)/streptomycin (100 mg/mL) solution (P/S, cat. no. 0503). HASMCs were incubated in SMCM and maintained at 37 C in 5% CO 2 /95% mixed ambient air. HASMC experiments were performed on 5 to 8 passages. HASMCs were grown to 80-90% confluence and made quiescent by serum starvation (0.2% BSA) for at least 12 h; 2.5 mmol/L, 5.0 mmol/L and 10.0 mmol/L of GSPB2 were added for preincubation for 1 h. Control cells were treated with same level of DMSO. After this preincubation, HASMCs were separately stimulated with 200 mg/mL of AGEs or unmodified BSA for defined periods.
Cell viability analysis. The cells were harvested by trypsinization to examine the effects of GSPB2 on HASMC proliferation. The cell viability was measured by microscopic examination after trypan blue dye exclusion, and cell survival was estimated with an MTT colorimetric assay. HASMCs (1 Â 10 6 cells/mL) were incubated in 96-well plastic culture plates for 48 h at 37 C in the presence or absence of different concentrations of GSPB2. The cells were then incubated with or without different concentrations of GSPB2 for 1 h, before being stimulated for 48 h with 200 mg/mL of AGEs or unmodified BSA. MTT was added at a final concentration of 0.5 mg/mL. After incubating at 37 C for an additional 4 h, the cells were centrifuged for 10 min at 1000 rpm, the supernatant was removed, and the cells were dissolved in 120 mL of isobutanol (containing 0.04 mol/L of HCl) and read at 570 nm by a microplate reader.
Cell migration assay. HASMC migration was evaluated by using 24-well Transwell cell culture chambers with 8.0-mm pore polycarbonate filter inserts. All cells were serum starved for 12 h prior to the migration assay to exclude all effects attributable to factors present in the serum other than the expected chemo-attractant. Cultured HASMCs were trypsinized and suspended in 0.2% BSA at a concentration of 4 Â 10 5 /mL. A total of 200 mL of 0.2% BSA was added to the filters, and the chamber was incubated at 37 C in 5% CO 2 for 48 h to allow cell migration. The insert was then removed, and the membrane was washed with 0.1 mol/L of phosphate-buffered saline. Any migrated cells on the upper side of filter were ignored, but the migrated cells on the lower side of the chamber were fixed and stained with hematoxylin. The membrane was mounted on a slide and then examined under a microscope, reading at 570 nm by a microplate reader.
Western blot analysis. A western blot analysis was performed on samples obtained from every group of HASMCs. Equal amounts of proteins were separated by SDS-PAGE (12%) and transferred on to polyvinylidene difluoride membranes (Millipore, Bedford, USA). The membranes were blocked with 5% (w/v) non-fat milk dissolved in TBS (Tris-buffered saline)-T [10 mmol/L Tris-HCl (pH 8.0), 150 mmol/L NaCl, and 1% Tween 20] for 1 h at room temperature and then incubated overnight at 4 C with the blocking solution containing the first antibody. After washing three times, the blot was incubated with a second antibody. The bands of interest were visualized with the enhanced DAB color reagent according to the manufacturer's recommendations. The luminosity of each identified protein band was quantified by a densitometric analysis (Digital Protein DNA Imagineware, Huntington Station, USA).
Immunoprecipitation and immunoblotting. Cells treated under different experimental conditions were quickly washed with ice-cold PBS containing 1 mmol/L Na 3 VO 4 , scraped off and lysed in a Nonidet P-40 lysis buffer [1% Nonidet P-40, 25 mmol/L HEPES (pH 7.5), 50 mmol/L NaCl, 50 mmol/L NaF, 5 mmol/L EDTA, 10 nmol/L okadaic acid, 1 mmol/L sodium orthoavanadate, 1 mmol/L phenylmethylsulfonyl fluoride, and 10 mmol/L aprotinin] for 10-15 min on ice. The insoluble material was removed by centrifugation at 14;000 g for 20 min at 4 C. The protein concentration was measured in the clear supernatant by using a kit (Bio-Rad Laboratories, Hercules, USA). A 50 mL amount of the 50% slurry of protein G Sepharose 4 Fast Flow was added to 1 mL of the cell lysate with an equal amount of protein, and the mixture incubated at 4 C for 1 h while gently shaking. The clear lysate was incubated with appropriate antibodies as indicated under constant agitation at 4 C for 2 h, and then further incubated for 1 h with protein G-Sepharose 4 Fast Flow. The immunoprecipitate was washed 4 times with the Nonidet P-40 lysis buffer. The whole cell lysate (20 mg) or immunoprecipitate was subjected to SDS-PAGE and electrotransferred on to a Hybond-ECL nitrocellulose membrane for immunoblotting. The membrane was incubated with 5% non-fat milk in TBST for 1 h at room temperature and then incubated overnight with the appropriate primary antibody at 4 C. The membrane was then washed twice with TBS-T and probed with the horseradish peroxidase-conjugated secondary antibody at room temperature for 1 h. The membrane was washed several times with TBS-T to remove any unbonded secondary antibodies and visualized with an ECL detection kit (Amersham Pharmacia Biotech). A densitometric analysis was performed by using a Las4000 luminescent image analyzer (Fujifilm).
Statistical analysis. Data are expressed as the mean AE standard deviation. A statistical analysis between groups was conducted by a one-way analysis of variance (ANOVA) followed by Tukey's HSD test for multiple comparisons. A p value <0:05 is considered statistically significant. All analyses were performed with SPSS for Windows software version 10.0 (SPSS, Chicago, USA).
Results

Effect of GSPB2 on the proliferation of AGE-exposed HASMCs
We performed an MTT proliferation assay to investigate the effect of GSPB2 on HASMC proliferation. Neither unmodified BSA nor DMSO had any effect on cell viability. The cell viability of AGEs was significantly higher by approximately 60% for 48 h (p < 0:01). Pretreating HASMCs with different concentrations of GSPB2 significantly improved the AGE-stimulated cell viability in a dose-dependent manner (p < 0:01) (Fig. 1) .
Effect of GSPB2 on the migration of AGE-exposed HASMCs
A Transwell migration chamber with a collagencoated polycarbonate filter was used to determine the effect of GSPB2 on HASMC migration. AGE-stimulated HASMCs significantly increased the number of migrating cells for 48 h (p < 0:01). However, pretreating HASMCs with different concentrations of GSPB2 significantly improved the AGE-stimulated cell migration in a dose-dependent manner (p < 0:01) (Fig. 2) .
Effect of GSPB2 on the expression of UCH-L1 in AGE-exposed HASMCs
We determined the effect of GSPB2 on the expression of UCH-L1 by western blotting. Stimulation of HASMCs with AGEs (200 mg/L) for 48 h significantly reduced the UCH-L1 protein expression. Pretreating with GSPB2 significantly improved the AGE-stimulated expression of UCH-L1 for 48 h (p < 0:05) (Fig. 3A and B) .
Effect of GSPB2 on the ubiquitination of IB-in AGE-exposed HASMCs
An immunoprecipitation analysis demonstrated the ubiquitination of IB-in HASMCs. Stimulation of HASMCs with AGEs resulted in an increased ubiquitination of IB-and lower level of IB-, whereas pretreating with GSPB2 significantly attenuated the degradation of IB-by affecting the ubiquitin-mediated protein degradation in AGE-exposed HASMCs (p < 0:05) (Fig. 4) .
Effect of GSPB2 on the nuclear translocation of NF-B in AGE-exposed HASMCs
We further examined how GSPB2 affected NF-B activation and nuclear translocation by western blotting. Stimulation of HASMCs with AGEs resulted in the increased nuclear translocation of NF-B p65. Pretreating with GSPB2 inhibited the nuclear translocation of NF-B p65 in AGE-exposed HASMCs (p < 0:05) ( Fig. 5A and B) .
Discussion
Macrovascular disease is the major cause of mortality in a diabetic patient population. 19, 20) The pathogenesis of macrovascular disease is characterized by the proliferation and migration of HASMCs within the intima and media. 21) AGEs have been associated with VSMC proliferation and migration in diabetic vasculopathy. 5) Many studies have demonstrated the impairment of AGEs on human umbilical-vein endothelial cells [22] [23] [24] Each result is expressed as a percentage of the untreated cells (100%) and is presented as the mean AE SD from six independent experiments. Ã p < 0:05, ÃÃ p < 0:01 compared with the control HASMC group; # p < 0:05, ## p < 0:01 compared with the AGEstimulated HASMC group. GSPB2, grape seed procyanidin B2; HASMCs, human aortic smooth muscle cells.
Fig. 2. Effects of GSPB2 on the Cell Migration of AGE-Stimulated
HASMCs.
Representative photographs are shown of HASMC migration during the Transwell assay. The data for migrated cells are expressed as the ratio of absorbance in HASMCs. Each result is presented as the mean AE SD from six independent experiments. Ã p < 0:05, ÃÃ p < 0:01 compared with the control HASMC group; # p < 0:05, ## p < 0:01 compared with the AGE-stimulated HASMC group. GSPB2, grape seed procyanidin B2; HASMCs, human aortic smooth muscle cells.
which cannot mimic the typical state in the aorta of diabetic patients. We used AGEs in this present study to stimulate HASMCs and approach the real pathological changes in the human macrovascular wall so that the results may provide more clinical sense.
AGEs have been linked to the neo-intimal formation after vascular injury in diabetes. 25) Numerous studies have revealed that AGEs would induce the production of reactive oxygen species (ROS) which triggers diabetic vascular remodeling and VSMC proliferation and migration. The interaction of AGEs with their receptor, RAGE (receptor for advanced glycation end products), which is expressed on the surface of VSMCs, contributes to the production of numerous pro-inflammatory factors through the activation of a variety of signal pathways, including p21 (ras), mitogen-activated protein kinase (MAPK), nuclear factor-B (NF-B), cyclooxygenase-2 and c-jun. 6, [26] [27] [28] [29] The increased oxidative stress contributes to VSMC dysfunctions, resulting in the activation of pro-inflammatory and prothrombotic pathways, and increased arterial stiffness. 6, 30) However, the underlying mechanism is unclear.
Although the morbidity and mortality of diabetes has increased year by year around the world, treatment is still restricted to a few classes of drugs. GSPB2, as a natural dietary supplement, displays an anti-oxidative property and protects against diabetic complications. 13, [31] [32] [33] The results of the present study reveal that GSPB2 inhibited the AGE-induced proliferation and migration of HASMCs, and that UCH-L1 may be involved in this process via the inhibition of NF-B activity.
Several animal and human studies have used antioxidants derived from such plants as green tea, resveratrol and Trigonella foenum graecum to combat diabetic complications, and their reports have demonstrated that antioxidative therapy has decreased the risk of diabetic outcomes. [34] [35] [36] Antioxidative therapy is therefore considered to be a promising strategy to prevent oxidative damage to VSMC in the early stage of diabetic vascular complications. 34 ) GSPE has been reported by some researchers to have limited bioavail-A B Fig. 3 . Effects of GSPB2 on the UCH-L1 Expression in AGEStimulated HASMCs (A and B). Data are presented as the expression ratio of UCH-L1/-actin and given as the mean AE SD from at least three separate experiments. Ã p < 0:05, ÃÃ p < 0:01 compared with the control HASMC group; # p < 0:05, ## p < 0:01 compared with the AGE-stimulated HASMC group. GSPB2, grape seed procyanidin B2; HASMCs, human aortic smooth muscle cells. ability; particularly, its absorption in the human body is unclear. However, many studies have shown that the administration of GSPE to diabetic rats effectively improved cardiovascular complications and had an antiatherosclerotic effect. 37, 38) A GSPE treatment has decreased the aortic pulse wave velocity and aortic medial thickness by reducing the expression of AGE and RAGE in diabetic aortas. 39) GSPE has also demonstrated protective effects against nephropathy, 32) retinopathy, 31) and damage to peripheral nerves 33) and the cerebral cortex 40) in STZ-induced diabetic rats. We found in this present study that HASMCs stimulated with AGEs had a higher migration cell number and increased proliferation when compared with unstimulated HASMCs in a dosedependent manner. Given that AGEs dysregulate VSMC growth and accelerate diabetic complications, GSPB2 may be helpful to prevent and treat vascular injury in diabetes. The mechanism by which GSPB2 blocked the AGE-induced HASMC proliferation and migration involved the regulation of UCH-L1 and ubiquitination of IB-.
UCH-L1, as a de-ubiquitinating enzyme, can hydrolyze the bonds between Ub and small adducts or unfolded polypeptides. 41) Recent studies have reported that UCH-L1 exhibited anti-angiogenesis activity by affecting the development of choroidal new vessels in age-related macular degeneration disease. 42, 43) Our previous experiments have shown that the expression of UCH-L1 in the retinopathy of diabetic rats was significantly lower than that of control rats by the proteomic technique. Treating with GSPE significantly increased the expression of UCH-L1 in diabetic rats. 31) Moreover, recent evidence has shown that UCH-L1 negatively regulated TNF--mediated VSMC proliferation by suppressing ERK activation. 44) Our data in this present work show that pretreating HASMCs with GSPB2 enhanced the expression of UCH-L1 and reduced the ubiquitination of IB-. UCH-L1 with the function of de-ubiquitination may reverse the ubiquitination process of IB-and allow ubiquitinated IBto escape from degradation by proteosomes.
12) UCH-L1 is therefore most likely to participate in the deterioration of diabetic complications as an important protein and provide novel targets for GSPE treatment.
It is well established that NF-B is involved in the AGE-mediated effects of RAGE signaling.
5) The ubiquitin-proteasome system has been shown to play a crucial role in the activation of NF-B under conditions of oxidative stress such as atherosclerosis and diabetes.
9,45) Activated nuclear NF-B has been detected in VSMCs after balloon injury to rat carotid arteries and in VSMCs of human atherosclerotic lesions. [46] [47] [48] Research has confirmed that NF-B had a close relationship with the proliferation and migration of VSMCs. We observed in this present work that the expression of NF-B was markedly enhanced in the cytoplasm and reduced in the nucleus of AGE-exposed HASMCs that had been pretreated with GSPB2, suggesting that its translocation to the nucleus was effectively inhibited by GSPB2. IB-, the inhibitor of NF-B in the cytoplasm, prevents translocation of NF-B into the nucleus. Oxidative stress activates IB kinase which phosphorylates IB-and induces ubiquitination and proteasomal degradation of IB-. 8) We observed here that pretreatingt with GSPB2 attenuated the production of ubiquitinated IB-, leading to decreased degradation of IB-. This suggests that GSPB2 mediated IB-protein expression, at least in part, through the ubiquitin-proteasome pathway. The up-regulation of UCH-L1 protein by a GSPB2 treatment also verified its de-ubiquitinating effect on IB-, 12) indicating that GSPB2 may inhibit nuclear translocation of NF-B by up-regulating UCH-L1 in AGE-stimulated HASMCs.
We report for the first time in this present study that GSPB2, one of the main components of GSPE, inhibited the AGE-induced proliferation and migration of HASMCs. This was achieved by inhibiting the nuclear translocation of NF-B and the degradation of its inhibitor, IB-, in the cytoplasm of HASMCs. These molecular events may have been the result of the upregulation of UCH-L1 by GSPB2 which can reverse the ubiquitination of IB-. Taken together, the results of our study suggest that the regulation of UCH-L1, IBand NF-B by GSPB2 contributed to improvement of the VSMC dysfunction resulting from damage by AGEs; this action could exert a protective effect on the vasculopathy in diabetes mellitus.
